- Home
- BMY vs MELI Comparison
BMY vs MELI Comparison
Compare BMY & MELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- MELI
- Stock Information
- Founded
- BMY 1887
- MELI 1999
- Country
- BMY United States
- MELI Uruguay
- Employees
- BMY N/A
- MELI N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- MELI Catalog/Specialty Distribution
- Sector
- BMY Health Care
- MELI Consumer Discretionary
- Exchange
- BMY Nasdaq
- MELI Nasdaq
- Market Cap
- BMY 110.2B
- MELI 95.5B
- IPO Year
- BMY N/A
- MELI 2007
- Fundamental
- Price
- BMY $58.21
- MELI $1,916.51
- Analyst Decision
- BMY Hold
- MELI Strong Buy
- Analyst Count
- BMY 14
- MELI 15
- Target Price
- BMY $53.92
- MELI $2,257.33
- AVG Volume (30 Days)
- BMY 11.9M
- MELI 558.2K
- Earning Date
- BMY 10-31-2024
- MELI 11-06-2024
- Dividend Yield
- BMY 4.11%
- MELI N/A
- EPS Growth
- BMY N/A
- MELI 43.80
- EPS
- BMY N/A
- MELI 28.12
- Revenue
- BMY $47,435,000,000.00
- MELI $18,493,000,000.00
- Revenue This Year
- BMY $6.54
- MELI $42.94
- Revenue Next Year
- BMY N/A
- MELI $24.58
- P/E Ratio
- BMY N/A
- MELI $68.15
- Revenue Growth
- BMY 5.56
- MELI 34.99
- 52 Week Low
- BMY $39.35
- MELI $1,324.99
- 52 Week High
- BMY $61.08
- MELI $2,161.73
- Technical
- Relative Strength Index (RSI)
- BMY 61.07
- MELI 44.11
- Support Level
- BMY $55.82
- MELI $1,848.00
- Resistance Level
- BMY $59.73
- MELI $2,004.62
- Average True Range (ATR)
- BMY 1.67
- MELI 61.24
- MACD
- BMY 0.11
- MELI -9.81
- Stochastic Oscillator
- BMY 61.84
- MELI 44.75
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About MELI MercadoLibre Inc.
MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions as of the end of 2023. The company operates a host of complementary businesses to its core online shop, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago and Mercado Credito), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.